These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 7905463)
1. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Massad G; Lockatell CV; Johnson DE; Mobley HL Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463 [TBL] [Abstract][Full Text] [Related]
2. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698 [TBL] [Abstract][Full Text] [Related]
3. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Li X; Johnson DE; Mobley HL Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487 [TBL] [Abstract][Full Text] [Related]
4. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474 [TBL] [Abstract][Full Text] [Related]
5. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Zunino P; Sosa V; Allen AG; Preston A; Schlapp G; Maskell DJ Microbiology (Reading); 2003 Nov; 149(Pt 11):3231-3237. PubMed ID: 14600235 [TBL] [Abstract][Full Text] [Related]
6. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805 [TBL] [Abstract][Full Text] [Related]
7. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection. Zhao H; Li X; Johnson DE; Mobley HLT Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698 [TBL] [Abstract][Full Text] [Related]
8. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418 [TBL] [Abstract][Full Text] [Related]
9. Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly. Li X; Zhao H; Geymonat L; Bahrani F; Johnson DE; Mobley HL Infect Immun; 1997 Apr; 65(4):1327-34. PubMed ID: 9119470 [TBL] [Abstract][Full Text] [Related]
10. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737 [TBL] [Abstract][Full Text] [Related]
11. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Jones BD; Lockatell CV; Johnson DE; Warren JW; Mobley HL Infect Immun; 1990 Apr; 58(4):1120-3. PubMed ID: 2180821 [TBL] [Abstract][Full Text] [Related]
12. Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. Massad G; Mobley HL Gene; 1994 Dec; 150(1):101-4. PubMed ID: 7959033 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373 [TBL] [Abstract][Full Text] [Related]
14. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Mobley HL; Belas R; Lockatell V; Chippendale G; Trifillis AL; Johnson DE; Warren JW Infect Immun; 1996 Dec; 64(12):5332-40. PubMed ID: 8945585 [TBL] [Abstract][Full Text] [Related]
15. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Jansen AM; Lockatell V; Johnson DE; Mobley HL Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655 [TBL] [Abstract][Full Text] [Related]
16. Repression of bacterial motility by a novel fimbrial gene product. Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949 [TBL] [Abstract][Full Text] [Related]
18. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. Zunino P; Geymonat L; Allen AG; Legnani-Fajardo C; Maskell DJ FEMS Immunol Med Microbiol; 2000 Oct; 29(2):137-43. PubMed ID: 11024353 [TBL] [Abstract][Full Text] [Related]
19. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Bahrani FK; Johnson DE; Robbins D; Mobley HL Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106 [TBL] [Abstract][Full Text] [Related]
20. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Johnson DE; Russell RG; Lockatell CV; Zulty JC; Warren JW; Mobley HL Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]